Advanced Glioblastoma Surgery in India: Costs vs US and UK
A glioblastoma diagnosis moves fast. Within days of learning the name, doctors and family will likely ask you to decide where to have surgery, which surgeon to trust, and how to pay for it. For many patients outside India - and even for those inside India who are weighing private hospital options - understanding what advanced surgical techniques are available, and what they cost in different countries, is helpful to know right now.
This article explains three techniques that may influence how much tumor your surgeon can safely remove: fluorescence-guided surgery with 5-ALA, awake craniotomy with brain mapping, and intraoperative neuromonitoring. It then compares approximate costs in India, the United States, and the United Kingdom, and walks through how international patients typically arrange surgery at an Indian neurosurgical center.
The goal here is practical information, not a sales pitch. Surgery for glioblastoma carries real risks regardless of country. The right center for you depends on your tumor location, your neurological status, your surgeon's experience, and factors no article can fully assess.
Why the extent of resection matters in glioblastoma
Glioblastoma is a high-grade brain tumor that tends to grow into surrounding healthy tissue rather than forming a clean border. Surgeons aim to remove as much tumor as possible - a concept called maximal safe resection - because research consistently links greater tumor removal to longer progression-free survival. The word "safe" matters here. Removing too much tissue in the wrong area can cause permanent neurological damage, which reduces both quality of life and the ability to tolerate subsequent chemotherapy or radiation.
The challenge is that glioblastoma cells can be nearly impossible to distinguish from normal brain tissue under standard white light. Several technologies have been developed specifically to help surgeons see tumor tissue more clearly and protect healthy brain at the same time.
What is fluorescence-guided surgery with 5-ALA?
5-ALA (5-aminolevulinic acid) is an oral medication taken by the patient a few hours before surgery. Glioblastoma cells absorb it and convert it into a compound that glows pink-red under a specific wavelength of violet-blue light. When the surgeon switches to fluorescence mode on the microscope, tumor tissue lights up while healthy brain does not.
A systematic review and meta-analysis of prospective studies found that 5-ALA-guided surgery increased complete resection rates from approximately 36% to 65% compared to standard white-light surgery - a substantial difference in the proportion of patients achieving full removal of visible tumor. A comparative cohort study of 343 glioblastoma patients found that patients who achieved complete resection of all fluorescing tissue had a mean survival of approximately 23 months, with longer progression-free and overall survival compared to patients with incomplete resection.
In the United States, 5-ALA received FDA approval in 2017 under the brand name Gleolan. In Europe, it has held regulatory authorization since 2007. India's leading private neurosurgical centers now offer this technique routinely. To understand how the dye reaches tumor cells at a molecular level, see our guide on fluorescence-guided surgery for glioma and how 5-ALA helps surgeons see invisible tumor cells.
What is awake craniotomy and when is it appropriate?
An awake craniotomy is a procedure in which you stay conscious during part of the surgery. This is not as alarming as it sounds. The skull and scalp have nerves that can be numbed with local anesthetic. The brain itself does not feel pain. By keeping you awake, the surgical team can ask you to speak, move your hand, or answer questions while they map the brain tissue near the tumor in real time.
This mapping - called intraoperative brain mapping - allows the surgeon to identify which areas are responsible for speech, language, or motor function before cutting. The goal is to push the boundary of resection as close to the tumor edge as possible without crossing into tissue that would cause permanent deficits.
A 2020 systematic review and meta-analysis found that awake craniotomy for supratentorial glioblastoma is associated with a low rate of persistent postoperative neurological deficits while allowing acceptable gross total resection rates. The technique is most commonly used when the tumor sits near areas that control speech or movement. It requires a neurosurgeon with specific training and a neuropsychologist or speech therapist present in the operating room. For more on how cortical mapping protects brain function, see our article on awake brain surgery and intraoperative brain mapping for speech and cognition protection.
What is intraoperative neuromonitoring?
Intraoperative neuromonitoring (IONM) refers to a set of real-time techniques used during surgery to track the function of specific neural pathways while you are under general anesthesia. A neurophysiologist monitors the signals continuously and alerts the surgeon if a pathway shows signs of stress, giving the surgical team the chance to adjust their approach before a deficit becomes permanent.
Research shows that neurophysiological monitoring plays a critical role in guiding glioma surgery by helping maximize resection while minimizing permanent neurological harm. Common IONM modalities used in glioblastoma surgery include:
- Motor evoked potentials (MEPs) - track the motor pathways from the brain to the limbs
- Somatosensory evoked potentials (SSEPs) - track sensory pathways from the body to the brain
- Direct cortical stimulation - identifies the motor cortex directly before it is approached
- Electrocorticography (ECoG) - records electrical activity from the brain surface
- Language mapping - used during awake procedures to identify speech areas
IONM is now standard practice at most large neurosurgical centers. Its availability at the hospital you are considering is a reasonable question to raise before committing to a center.
What does glioblastoma surgery cost in India, the US, and the UK?
| Factor | India (private hospital) | United States | United Kingdom (private) |
|---|---|---|---|
| Craniotomy cost (2025) | USD 5,500-8,500 for standard craniotomy at private hospitals; advanced techniques with 5-ALA and neuromonitoring add to this total - request a written quote from the specific center | Highly variable by hospital and insurance status; generally among the highest globally for self-pay patients; awake craniotomy adds approximately USD 2,175 in intraoperative cost vs general anesthesia (2021 cost analysis) | GBP: varies by hospital and procedure complexity - request a written quote directly; NHS-funded for eligible UK residents |
| 5-ALA fluorescence-guided surgery | Available at major private neurosurgical centers in Chennai, Mumbai, Delhi, and Hyderabad; confirm with the specific hospital before booking | Available at academic medical centers across the country; received FDA approval in 2017 as Gleolan | Available at NHS neurosurgical units and private hospitals; approved by NICE for high-grade glioma |
| Awake craniotomy | Offered at select high-volume private centers; requires a trained team including a neuropsychologist or speech therapist - verify availability and team experience directly with the center | Available at major academic centers and comprehensive cancer programs; specialist team required | Available at NHS neurosurgical units and major private hospitals; specialist team required |
| Intraoperative neuromonitoring (IONM) | Available at leading private hospitals; standard at high-volume centers; confirm at the specific facility | Standard of care at most accredited neurosurgical programs | Standard at NHS neurosurgical units and major private hospitals |
| Wait time for international patients | Typically 1-2 weeks from inquiry to surgery date at leading private hospitals; some centers can move faster | Variable; major academic centers may have longer scheduling timelines for new patients | Private hospitals generally faster than NHS waitlists; NHS timelines for international self-pay patients vary |
India cost range sources: Hospidio India cost guide (2025); Lyfboat India neurosurgery cost guide (2025). US awake craniotomy cost differential: PubMed - Awake vs Asleep Craniotomy Cost Analysis (2021). All figures are approximate and subject to change. Request a written itemized quote from any hospital before making financial commitments.
India's private neurosurgical centers offer the techniques described in this article at a fraction of the cost facing self-pay patients in the US or UK. The cost difference comes from lower hospital operating costs and lower physician fees in India - not from differences in the underlying surgical technology. Major private hospitals in India use the same fluorescence microscopes, the same 5-ALA protocol, and the same IONM equipment that Western academic centers use. For a broader breakdown of what the full course of glioblastoma treatment costs across countries, see this guide on glioblastoma treatment costs in the USA, India, and Europe.
Is the quality of neurosurgery in India comparable to the US and UK?
This is the right question to ask. The honest answer is: it depends on the specific hospital and surgeon, just as it does in the US or UK. A small number of high-volume private centers in India perform hundreds of brain tumor operations per year, and outcomes at these centers match published benchmarks from Western academic institutions. Surgical volume is one of the best-studied measures of outcome quality in complex procedures.
Quality varies considerably across Indian hospitals. A hospital's name or city does not guarantee quality. Ask about the surgeon's specific experience with glioblastoma, the number of 5-ALA-guided resections performed per year, whether a dedicated neurophysiologist performs IONM, and what the ICU protocol looks like after surgery. Accreditation by the National Accreditation Board for Hospitals and Healthcare Providers (NABH) in India, or by Joint Commission International (JCI), provides a baseline signal of quality management systems - though accreditation alone does not guarantee surgical outcomes.
Getting an independent expert review before committing to a surgical plan and center is a helpful step families can take. If you want to explore precision-oncology options through Art of Healing Cancer, their team provides independent case review that can help you compare surgical centers and treatment plans across countries before you decide.
How do international patients arrange glioblastoma surgery in India?
The logistics are manageable with planning. Here is how the process typically works:
- Gather your records. Collect MRI scans in DICOM digital format (on a CD or downloaded from a patient portal), the pathology or biopsy report, any prior operative notes, and a current medication list. Most Indian hospitals will want DICOM files, not printed images.
- Submit records to candidate hospitals. Most major private hospitals in India have international patient departments that accept records by email or online portal. Expect a preliminary opinion and cost estimate within 24-72 hours.
- Request a direct video consultation with the surgeon. Before traveling, speak with the neurosurgeon who will actually operate - not only with a hospital coordinator. Use this call to ask specific questions about their 5-ALA experience, IONM setup, and awake craniotomy capability if relevant to your tumor location.
- Apply for a medical visa. India issues a specific medical visa category (MV) for patients traveling for treatment. You will need an invitation letter from the treating hospital. Allow at least two weeks for processing, though timelines vary by country of origin.
- Plan for a companion. Indian hospitals encourage one caregiver to travel with the patient. Your companion will need their own visa and accommodation. Many hospitals offer on-site or nearby guest house options.
- Budget for the full stay. Surgery is typically followed by a hospital recovery period and observation before you are cleared to fly. Plan for a minimum of three to four weeks in country, though your surgeon will give a more specific estimate based on your case.
- Arrange post-travel oncology care at home. The standard post-surgical protocol for glioblastoma - concurrent radiation and temozolomide chemotherapy - typically begins approximately four weeks after surgery. Identify a neuro-oncologist at home who can continue your care before you travel.
Questions to ask your neurosurgeon before surgery
Whether you are evaluating a surgeon in India, the US, the UK, or elsewhere, these questions are worth raising directly with the person who will operate:
- How many glioblastoma resections do you perform per year, and how many use 5-ALA fluorescence guidance?
- Is my tumor in a location where awake craniotomy could increase the extent of safe resection?
- Who performs intraoperative neuromonitoring during my surgery - a dedicated neurophysiologist or the surgical team?
- What is your center's rate of permanent neurological deficit after glioblastoma resection?
- What imaging will you use immediately after surgery to confirm the extent of resection?
- What is the plan if the tumor is near a critical area and complete resection is not safely achievable?
- How does your center coordinate with the radiation oncology and neuro-oncology team to begin post-surgical treatment?
- What is included in the surgical quote, and what costs might arise beyond the initial estimate?
When to talk to your doctor
If you have recently received a glioblastoma diagnosis, the most time-sensitive step is to speak with a neurosurgeon who can review your specific MRI and give you a surgical recommendation based on your tumor's size, location, and your overall health. If the surgeon managing your case does not use 5-ALA, awake craniotomy, or intraoperative neuromonitoring, and your tumor is near a region that controls speech, movement, or vision, it is reasonable to ask whether a second surgical opinion makes sense.
If you are considering surgery outside your home country and want specialists to review your imaging and reports before committing to travel, you can upload records and request a remote review through the Glioblastoma Center patient-journey form.
This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.